Andelyn Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Andelyn Biosciences's estimated annual revenue is currently $40.6M per year.
- Andelyn Biosciences's estimated revenue per employee is $155,000
Employee Data
- Andelyn Biosciences has 262 Employees.
- Andelyn Biosciences grew their employee count by 14% last year.
Andelyn Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | General Counsel, Chief Compliance Officer, and Corporate Secretary | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Information Technology | Reveal Email/Phone |
4 | Head Manufacturing | Reveal Email/Phone |
5 | Head Engineering | Reveal Email/Phone |
6 | Head Quality | Reveal Email/Phone |
7 | Head Process Development | Reveal Email/Phone |
8 | Head Analytical Development | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Associate Director Manufacturing | Reveal Email/Phone |
Andelyn Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $1.7M | 11 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $5.1M | 33 | 14% | N/A | N/A |
#5 | $64.6M | 417 | 2% | N/A | N/A |
#6 | $1.7M | 11 | -8% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $7.4M | 48 | -41% | N/A | N/A |
#9 | $0.6M | 4 | 0% | N/A | N/A |
#10 | $0.9M | 12 | 20% | N/A | N/A |
What Is Andelyn Biosciences?
Beginning operations in late 2020, Andelyn Biosciences will be a Phase 3 compliant Good Manufacturing Practices (cGMP) clinical manufacturing facility producing gene therapy and cell-based products. Andelyn Biosciencesᅢᄁ¬ツᆲ¬トᄁ unique business model leads to reinvestment into pioneering research conducted at the Abigail Wexner Research Institute at Nationwide Children's on a broad range of challenges affecting childrenᅢᄁ¬ツᆲ¬トᄁs health.
keywords:N/AN/A
Total Funding
262
Number of Employees
$40.6M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Andelyn Biosciences News
2022-04-06 - Global Lentiviral Vector Manufacturing Market Size
... Pall Corporation, ITSBio Inc., ANDELYN BIOSCIENCES, Sino Biological Inc., Cellomics Technology, LLC, Virica Biotech, Cell Biolabs, Inc.,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $65.4M | 262 | 2% | N/A |
#2 | $28.9M | 263 | 0% | N/A |
#3 | $7.5M | 264 | 14% | N/A |
#4 | $84.5M | 265 | 6% | N/A |
#5 | $66.4M | 266 | 45% | N/A |